Innova Captab Ltd IPO

About Company

Incorporated in 2005, Innova Captab Limited is an integrated pharmaceutical company in India with a footprint spanning the entire pharmaceutical value chain, the company is involved in various aspects, such as research and development, manufacturing, marketing, drug distribution and exports.

The company’s business includes 3 categories: 1. A Contract Development and Manufacturing Organisation (CDMO) business that offers manufacturing services to pharmaceutical companies in India; 2. A domestic branded generics business, and 3. An international branded generics business. 

The company’s CMDO business has relationships with key players in the Indian pharma industry, such as Cipla Limited, Wockhardt Limited, Glenmark Pharmaceuticals Limited, Corona Remedies Private Limited, Lupin Limited, Emcure Pharmaceuticals Limited and more. In the branded generics business, they cover therapeutic areas such as Cephalosporins, Antidiabetic, Antispasmodic, Antifibrinolytic, Cardiovascular, Antioxidant and Vitamins, Anti Hyperuricemia and Antigout, etc. Their international branded generics business is expanded to regulated markets like Canada and the UK. They have two manufacturing plants in Baddi, Himachal Pradesh.

The Indian trade generics industry exhibited robust growth, achieving a healthy CAGR of 7.4% from ₹63 billion in FY 2018 to ₹91 billion in FY 2023. Projections indicate a continued upward trajectory, with the industry expected to grow at a CAGR of 9.5-10.5% from FY 2023, reaching an estimated ₹140-150 billion by the conclusion of FY 2028. This shows that there is a potential opportunity for Innova Captab Limited. 

Innova Captab Limited IPO Details

Innova Captab Limited IPO Date 

Innova Captab Limited’s IPO will open on December 21, 2023, and close on December 26, 2023. The IPO will be listed on the NSE and BSE on December 29, 2023.

Innova Captab Limited IPO Price Band

Innova Captab Limited is a fresh issue and Offer for Sale. The issue size and price band are not yet announced.

Innova Captab Limited IPO Lot Size

Innova Captab Limited’s IPO lot size is 33 shares in one lot.

Innova Captab Limited IPO Objectives 

The objectives of Innova Captab Limited's IPO are listed below:

• To repay or prepay, in full or part, of certain outstanding company loans.
• To invest in their subsidiary, UML, to repay or prepay in part or full of outstanding loans availed by UML. 
• For general corporate purposes. 
• To fund the additional working capital requirements. 

Peer Details

As per RHP, Torrent Pharmaceuticals Limited, Laurus Labs Limited, Ajanta Pharma Limited, J. B. Chemicals and Pharmaceuticals Limited, NATCO Pharma Limited, Eris Lifesciences Limited, Indoco Remedies Limited, Suven Pharmaceuticals Limited and Windlas Biotech Limited are the listed peers whose business portfolio is comparable to the company.

How To Check the Innova Captab Limited Allotment Status?

Steps to check IPO allotment status on Angel One’s app:

• Log in to the Angel One app
• Go to the IPO Section and then to IPO Orders
• Select the individual IPO that you had applied for and check the allotment status.
• Angel One will notify you of your IPO allotment status via push notification and email.

Open a demat account with Angel One to apply for the Innova Captab Limited IPO.

Contact Details of Innova Captab Limited IPO

• Registered office: 601, Proxima, Plot No. 19, Sector 30 A, Vashi, Navi Mumbai, Maharashtra 400 705, India. 
• Phone: +91 1724194500
• E-mail: investors@innovacaptab.com